Health is a Political Choice: Global Leaders Call for Shared Responsibility at the World Health Summit, Gallup and GPMB Release Landmark Reports on Emotional Wellbeing and Pandemic Preparedness
more
Stories about Health / Medicine
Germans would value more trustworthy online health information
Gütersloh (ots) - Most people these days look online for answers to questions on health. However, many have doubts on the integrity and quality of the information provided by social media platforms and AI chatbots. The Bertelsmann Stiftung would like to contribute to promoting reliable sources and increasing confidence in digital information on health by means of its ...
moreIEVA (Independent European Vape Alliance)
WHO must embrace harm reduction at COP11 to truly drive down global smoking rates
Brussels (ots) - As the 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) approaches (17–22 November 2025, Geneva), the Independent European Vape Alliance (IEVA) calls on the World Health Organization (WHO) and its member states to finally place harm reduction at the centre of the global tobacco control debate. IEVA ...
moreLetter of Intent for strategic partnership / Vaccentis and TrueMed join forces to advance cancer vaccine
Zurich (ots ZurichZurich) - Vaccentis, a Zurich based biotech company specializing in the development of therapeutic protein-based tumor vaccines, has signed a letter of intent with TrueMed, a leading commercialization partner. Accelerating cancer vaccine against renal cell carcinoma The aim of this letter of intent ...
moreData4Life and EvidNet form strategic partnership to advance federated real-world evidence generation
Seoul, South Korea & Potsdam, Germany (ots) - Data2Evidence meets FeederNet: Joining forces for scalable, standardized, and responsible health research infrastructure Nonprofit digital health organization Data4Life and South Korea’s leading federated research platform EvidNet today announced a strategic ...
moreFAMAR Group: Dr. Riku Rautsola Appointed New CEO
Athens, Greece (ots/PRNewswire) - After 16 years with FAMAR, including the last 4 years as CEO, Konstantinos Rengis decided to step down from his role for personal reasons, effective September 29, 2025. Kostas is widely recognized for his customer-centric approach, deep knowledge of our industry, and his solution-oriented mindset. During his tenure, he played a pivotal role in successfully guiding the company through ...
moreAsklepios Kliniken GmbH & Co. KGaA
2Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
moreServier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Suresnes, France (ots/PRNewswire) - - Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company - KER-0193, a novel, orally bioavailable small molecule, was granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA - Acquisition ...
moreAsklepios Kliniken GmbH & Co. KGaA
Nominations for the Broermann Medical Innovation Award 2026 now open
Hamburg (ots) - - With a million euros, it is one of the world’s most highly endowed awards for medical research The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made ...
moreGrünenthal PRO is joining SHL Medical’s alliance partnership network to offer final assembly service for Molly® autoinjectors
Aachen (ots) - Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery ...
moreData4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation
moreUCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
moreHealth in the fast lane: How modern car seats protect our backs
Bremervörde (Germany) (ots) - From autonomous driving to advanced safety technologies – the innovations presented at the IAA Mobility captivate car enthusiasts. However, one key comfort factor is often overlooked: the car seat. To meet the demand for ergonomic design, the production has become increasinglycomplex – up to 12 percent of a car’s development costs are attributable to the seat. “But not every seat ...
moreCannovum Health welcomes new strategic majority investor – Triple Crown Ventures becomes main shareholder
moreMikrona Group Acquires FTC Dental
Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona Group is part of Healthcare Holding Schweiz AG, which is managed by Winterberg Advisory and KKA Partners. Healthcare Holding Schweiz AG, through its subsidiary Mikrona Group AG, has completed the acquisition of FTC Frey Trading & ...
moreCroma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
moreSingapore-Based Innovative Biomedical Start-Up Achieves “Strategic Triumph“ to Conquer Chinese Med-Tech Market
Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the company’s history; product approval in China was the company’s ...
moreABDA Bundesvgg. Dt. Apothekerverbände
Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available
Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the ...
moreGroupement Hospitalier Loos Haubourdin confirms its partnership with Intalio and Officially Adopts the Intalio Assure Digital Solution
Paris (ots/PRNewswire) - After two years of co-development marked by close collaboration, Groupement Hospitalier Loos Haubourdin (GHLH) has renewed its trust in Intalio, a recognized leader in digital transformation for organizations, by officially adopting the Intalio Assure solution, the digital version of the ...
moreWorld Health Summit 2025: Registration Open - First High-Level Speakers Announced
Berlin (ots) - Registration for the World Health Summit 2025 is now open. From October 12-14, Berlin will once again host one of the most important strategic global health gatherings worldwide. Under the theme "Taking Responsibility for Health in a Fragmenting World", the summit brings together leading minds from academia, politics, the private sector, and civil ...
moreIchnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today announced an ...
moreAxolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis
moreIntuitive Surgical Deutschland GmbH
Intuitive’s da Vinci 5 Surgical System Receives CE Mark / Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
moreHagleitner Hygiene International GmbH
Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year
moreMedison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer
Petach Tikva, Israel (ots/PRNewswire) - Strategic appointments reflect Medison's continued investment in global scale and operational excellence Medison, the creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of breakthrough therapies in markets beyond the U.S., ...
moreIsomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence
London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly ...
moreMedHub-AI and Terumo partner to market AI-based FFR in Japan
Tel Aviv, Israel (ots/PRNewswire) - MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This partnership marks a new era in coronary physiology assessment where AI technology delivers superior confidence, reproducibility, and clinical ...
moreInnovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250
Munich (ots/PRNewswire) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor targeting herpes simplex virus ...
moreHealthcare Holding Switzerland Acquires Ino Medical Solutions
Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Ino Medical Solutions GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. Healthcare Holding Schweiz AG has successfully completed the acquisition of Ino Medical Solutions GmbH, based ...
moreBIAL Announces Oral Presentation at GBA1 Meeting 2025
Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...
more
12345678910Next